Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?

Yıl 2022, Cilt: 9 Sayı: 2, 243 - 250, 30.06.2022

Yunus Durmaz , İlker İlhanlı , Betul Ustun Cetinkaya Kıvanç Cengiz

https://doi.org/10.34087/cbusbed.1032757

Öz

Objectives: To compare elderly-onset rheumatoid arthritis (EORA) patients with younger-onset rheumatoid arthritis (YORA) patients in terms of sociodemographic, clinical and radiological features, and treatment responses.
Materials and Methods: 422 rheumatoid arthritis (RA) patients were evaluated retrospectively. Patients with the age of onset of disease symptoms ≥60 were considered EORA, and those <60 were considered YORA. Sociodemographic characteristics, co-morbid diseases, laboratory values,joint involvement patterns, accompanying extra-articular findings,Simple Erosion Narrowing radiological scores(SENS) and the number of patients meeting the 1987 American College of Rheumatology-Rheumatoid Arthritis(ACR-RA) classification criteria were evaluated at the time of initial diagnosis.The doses of steroids and disease-modifying anti-rheumatic drugs(DMARDs) were recorded. Disease activity score with erythrocyte sedimentation rate (DAS28-ESR) at the beginning and 3rd month of DMARDs treatment were recorded.
Results: The frequency of EORA was 8.3%.The frequency of rheumatoid factor positivity(82.9%), co-morbid disease frequency(77.1%) and the mean value of erythrocyte sedimentation rate (62.0±25.21 mm/h) seen in patients with EORA were significantly higher than patients with YORA(55%,%19.9 and 33.97±19.48, respectively)(p<0.05).There was no significant difference between patients with EORA and patients with YORA in terms of the baseline DAS-28-ESR and C-reactive protein mean values,SENS median value,frequency of positive anti-cyclic citrullinated peptide,joint involvement frequency, frequency of meeting 1987 ACR-RA classification criteria, and frequency of steroid and DMARDs usage(p>0.05).There was no difference between the patients with EORA and YORA in terms of DAS28-ESR values measured at the 3rd month of treatment and steroid doses used(p>0.05).
Conclusion: There is no difference in many clinical and laboratory findings, especially disease activity scores and radiographic scores, in patients with EORA and YORA.

Anahtar Kelimeler

Elderly-Onset Rheumatoid Arthritis, Younger-Onset Rheumatoid Arthritis, Radiological Scoring

Yaşlı Başlangıçlı Romatoid Artrit, Genç Başlangıçlı Romatoid Artritten Farklı mı?

Öz

Giriş ve Amaç: Yaşlı başlangıçlı romatoid artritli (YBRA) hastaları, genç başlangıçlı romatoid artritli (GBRA) hastalar ile sosyodemografik, klinik, radyolojik ve tedavi yanıtları açısından karşılaştırmaktır.
Gereç ve Yöntemler: 2010 American College of Rheumatology-Rheumatoid Arthritis (ACR-RA) sınıflama kriterlerini karşılayan 422 romatoid artrit (RA) hastası geriye dönük olarak değerlendirildi. Hastalık semptomlarının başlangıç yaşı≥60 olan hastalar YBRA, <60 olanlar GBRA olarak kabul edildi. Sosyodemografik özellikler, komorbid hastalıklar, laboratuvar değerleri, eklem tutulum paternleri, eşlik eden eklem dışı bulgular, radyolojik skorlar ve 1987 ACR-RA sınıflama kriterlerini karşılayan hasta sayısı ilk tanı anında belirlendi. Steroid ve hastalık modifiye edici antiromatizmal ilaçların(HMEAİ) dozları kaydedildi. HMEAİ tedavisinin başlangıcında ve 3. ayında hastalık aktivite skoru(DAS28-ESR) incelendi.
Bulgular: YBRA sıklığı %8,3 idi. YBRA’li hastalarda romatoid faktör pozitiflik sıklığı (%82.9),komorbid hastalık sıklığı (%77.1) ve eritrosit sedimantasyon hızı ortalama değeri (62.0±25.21 mm/saat) GBRA’li hastalardan anlamlı derecede yüksekti (sırasıyla %55,%19.9 ve 33.97±19.48)(p<0.05). YBRA'lı hastalar ile GBRA'lı hastalar arasında; başlangıç DAS-28-ESR değerleri, C-reaktif protein ortalama değerleri, SENS medyan değeri, anti-siklik sitrüline peptid pozitiflik sıklığı, eklem tutulum patern sıklıkları, 1987 ACR-RA sınıflandırma kriterlerini karşılayan hasta sıklığı ve steroid ile HMEAİ kullanım sıklığı açısından anlamlı farklılık yoktu (p>0.05). Yine YBRA ve GBRA'lı hastalar arasında tedavinin 3. ayında ölçülen DAS28-ESR değerleri ve kullanılan steroid dozları açısından farklılık yoktu (p>0.05).
Sonuç: YBRA ve GBRA'lı hastalarda hastalık aktivite skorları ve radyografik skorlar başta olmak üzere birçok klinik ve laboratuvar bulgu arasında farklılık yoktur.

Anahtar Kelimeler

Genç Başlangıçlı Romatoid Artrit, Yaşlı Başlangıçlı Romatoid Artrit, Radyolojik Skorlama

Kaynakça

• Ozer PK, Sahin O, Ozer Z, Cengiz AK, Durmaz Y, Kaptanoglu E. Ultrasound-defined remission for good functional status in rheumatoid arthritis. Indian J Med Res 2017; 146: 230-6.
• Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int 2017; 37: 1551-7.
• Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010; 62: 1576-82.
• Laiho K, Tuomilehto J, Tilvis R. Prevalence of rheumatoid arthritis and musculoskeletal diseases in the elderly population. Rheumatol Int 2001; 20: 85-7.
• Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 2003; 48: 917-26.
• Villa-Blanco JI, Calvo-Alén J. Elderly Onset Rheumatoid Arthritis. Drugs & Aging 2009; 26: 739-50.
• Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994; 33: 735-9.
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
• Gensler LS. Glucocorticoids: complications to anticipate and prevent. Neurohospitalist 2013; 3: 92-7.
• van der Heijde D, Dankert T, Nieman F, Rau R, Boers M. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 941-7.
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
• Hair J BW, Babin B, Anderson R, Tatham R. Multivariate Data Analysis. Essex, England. In: Pearson Education Limited; 2013.
• Richter MD, Matteson EL, Davis JM, 3rd, Achenbach SJ, Crowson CS. Comparison of Biologic Discontinuation in Patients With Elderly-Onset Versus Younger-Onset Rheumatoid Arthritis. ACR Open Rheumatol 2019; 1: 627-31.
• Calvo-Alén J, Corrales A, Sánchez-Andrada S, Fernández-Echevarría MA, Peña JL, Rodríguez-Valverde V. Outcome of late-onset rheumatoid arthritis. Clin Rheumatol 2005; 24: 485-9.
• Krams T, Ruyssen-Witrand A, Nigon D, Degboe Y, Tobon G, Fautrel B, et al. Effect of age at rheumatoid arthritis onset on clinical, radiographic, and functional outcomes: The ESPOIR cohort. Joint Bone Spine 2016; 83: 511-5.
• Cho SK, Sung YK, Choi CB, Cha HS, Choe JY, Chung WT, et al. Do patients with elderly-onset rheumatoid arthritis have severe functional disability? Semin Arthritis Rheum 2012; 42: 23-31.
• Turkcapar N, Demir O, Atli T, Kopuk M, Turgay M, Kinikli G, et al. Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients. Arch Gerontol Geriatr 2006; 42: 225-31.
• El-Labban AS, Omar HA, El-Shereif RR, Ali F, El-Mansoury TM. Pattern of Young and Old Onset Rheumatoid Arthritis (YORA and EORA) Among a Group of Egyptian Patients with Rheumatoid Arthritis. Clin Med Insights Arthritis Musculoskelet Disord 2010; 3: 25-31.
• Tamas MM, Felea I, Rednic S. How much difference does the age at onset make in early arthritis patients? Comparison between the ACR 1987 and the ACR/EULAR 2010 classification criteria for rheumatoid arthritis at the time of diagnosis. Rheumatol Int 2013; 33: 2881-4.
• Terkeltaub R, Esdaile J, Décary F, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheumatol 1983; 10: 418-24.
• Deal CL, Meenan RF, Goldenberg DL, Anderson JJ, Sack B, Pastan RS, et al. The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum 1985; 28: 987-94.
• Lance NJ, Curran JJ. Late-onset, seropositive, erosive rheumatoid arthritis. Semin Arthritis Rheum 1993; 23: 177-82.
• Chen DY, Hsieh TY, Chen YM, Hsieh CW, Lan JL, Lin FJ. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease. Gerontology 2009; 55: 250-8.
• Takeda T. [Treatment strategy of elderly rheumatoid arthritis]. Nihon Rinsho Meneki Gakkai Kaishi 2016; 39: 497-504.